Get notified when TRVI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TRVI Trevi Therapeutics, Inc. 8-K

Trevi Therapeutics reports Q1 2026 financial results

Filed May 5, 2026 · Period ending May 5, 2026 · ~1 min read

Key Changes

  • medium

    Company announced financial results for the quarter ended March 31, 2026 via press release. Detailed financial metrics are contained in the furnished exhibit rather than the filing body.

    Item 2.02 verify on EDGAR →
  • low

    This is a routine quarterly earnings announcement with no unusual disclosures or material business events reported in the 8-K filing itself.

    8-K: Earnings verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.

Partner

Trade TRVI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify